Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-20

Clinical Trial Update: Incidence of Ultrasonographically Detected Articular Damage in Initially Healthy Joints of Patients With Hemophilia A Receiving Prophylactic Treatment With Emicizumab

View source ↗

Summary

A clinical trial update examining the incidence of ultrasound-detected articular damage in initially healthy joints of patients with Hemophilia A who are on emi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Emicizumab (emicizumab)

Snippet

Sponsor: Investigación en Hemofilia y Fisioterapia | Conditions: Hemophilia | Status: NOT_YET_RECRUITING